← Leaderboards
Danielle M Zerr
Seattle Children'S Hospital
$5,835,008
Attributed
$7,006,562
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2005–17$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$7,006,562 · 7
By mechanism
R01$5,999,462 · 3
K23$627,480 · 1
R56$378,005 · 1
M01$1,615 · 2
Top collaborators
- Scott J Weissman4 shared
Most similar at Seattle Children'S Hospital
Same institution · by research overlap
- Scott J Weissman$2,245,197
Others in their field
Top investigators on “Morbidity - Disease Rate”
- Marco Pahor · Wake Forest University Health Sciences$29,421,775
- A Benedict Cosimi · Massachusetts General Hospital$17,236,164
- Judith S. Currier · University Of California Los Angeles$11,229,603
- Andrea Jenay Ruff · Johns Hopkins University$10,896,035
- Lucile L Adams-Campbell · Howard University$10,384,616
- Michael K Ong · University Of California Los Angeles$9,898,332
Research focus
Morbidity - Disease RateMortality Vital StatisticsResourcesSiteResistanceMulti-Drug ResistanceAntimicrobial ResistanceExpenditureChildSpecimenPreventExposure ToBacteriaAntibioticsClinical DataInfectionClinical CareEnterobacteriaceaeSepsisHealthcareFutureIncidencePilot ProjectsPolymerase Chain Reaction
Grant awards (23)
Impact of chlorhexidine bathing on reducing infections in children with cancer$179,792
R01 · FY2017 · CA · contact PI
Impact of chlorhexidine bathing on reducing infections in children with cancer$542,687
R01 · FY2016 · CA · contact PI
Impact of chlorhexidine bathing on reducing infections in children with cancer$171,762
R01 · FY2015 · CA · contact PI
Impact of chlorhexidine bathing on reducing infections in children with cancer$353,172
R01 · FY2014 · CA · contact PI
National surveillance of emerging MDR in pediatric Enterobacteriaceae infections$568,479
R01 · FY2013 · AI · contact PI
Impact of chlorhexidine bathing on reducing infections in children with cancer$594,723
R01 · FY2012 · CA · contact PI
National surveillance of emerging MDR in pediatric Enterobacteriaceae infections$579,344
R01 · FY2012 · AI · contact PI
National surveillance of emerging MDR in pediatric Enterobacteriaceae infections$581,836
R01 · FY2011 · AI · contact PI
National surveillance of emerging MDR in pediatric Enterobacteriaceae infections$613,450
R01 · FY2010 · AI · contact PI
National surveillance of emerging MDR in pediatric Enterobacteriaceae infections$378,005
R56 · FY2009 · AI · contact PI
HHV-6 and CNS disease following stem cell transplant$278,321
R01 · FY2009 · AI · contact PI
HHV-6 and CNS disease following stem cell transplant$283,432
R01 · FY2008 · AI · contact PI
HHV-6 and CNS disease following stem cell transplant$291,912
R01 · FY2007 · AI · contact PI
VIRAL PATHOGENS AND FIRST TIME SEIZURES IN THE SETTING OF ILLNESS$77
M01 · FY2007 · RR · contact PI
HHV-6 and CNS disease following stem cell transplant$310,457
R01 · FY2006 · AI · contact PI
VIRAL PATHOGENS AND FIRST TIME SEIZURES IN THE SETTING OF ILLNESS$826
M01 · FY2006 · RR · contact PI
HHV-6 and CNS disease following stem cell transplant$318,426
R01 · FY2005 · AI
VIRAL PATHOGENS AND FIRST TIME SEIZURES IN THE SETTING OF ILLNESS$712
M01 · FY2005 · RR
HHV-6 and CNS disease following stem cell transplant$331,669
R01 · FY2004 · AI
DEFINING PRIMARY HHV-6 AND HHV7 INFECTIONS IN CHILDREN$158,220
K23 · FY2003 · AI
DEFINING PRIMARY HHV-6 AND HHV7 INFECTIONS IN CHILDREN$158,220
K23 · FY2002 · AI
DEFINING PRIMARY HHV-6 AND HHV7 INFECTIONS IN CHILDREN$158,220
K23 · FY2001 · AI
DEFINING PRIMARY HHV-6 AND HHV7 INFECTIONS IN CHILDREN$152,820
K23 · FY2000 · AI